心脈醫療(688016.SH):擬使用部分募集資金6000萬元對全資子公司上海藍脈增資
格隆匯 7 月 6日丨心脈醫療(688016.SH)公告,公司於2020年7月6日召開第一屆董事會第十二次會議,第一屆監事會第八次會議,審議通過了《關於使用部分募集資金對全資子公司進行增資實施募投項目的議案》,公司擬使用部分募集資金6,000萬元對公司全資子公司上海藍脈醫療科技有限公司進行增資(含前期公司已向上海藍脈提供的500萬元借款),本次增資6,000萬元全部計入上海藍脈的註冊資本,公司監事會、獨立董事對上述議案發表了明確同意的意見。
上海藍脈作為募投項目主動脈及外周血管介入醫療器械研究開發項目的實施主體,開展募投項目中相關靜脈血管介入醫療器械的研發,為增強其整體實力,促進其業務發展,優化其資本結構,公司擬使用部分募集資金6,000萬元對全資子公司上海藍脈進行增資實施募投項目(含前期公司已支付至上海藍脈的500萬元借款),全部計入註冊資本。增資完成後,上海藍脈的註冊資本將變更為6,500萬元人民幣,公司仍持有其100%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.